T Cell News and Research

Latest T Cell News and Research

Eosinophils contribute to antiviral host defense mechanisms during influenza

Eosinophils residing in the airways of mice respond to influenza A virus infection through alterations in surface expression of various markers necessary for migration and cellular immunity responses, according to research published in the Journal of Leukocyte Biology by researchers from Le Bonheur Children's Hospital and the University of Tennessee Health Science Center.

5 Aug 2020

A combination of silk scaffolds and magnetism for regenerating bone tissue

The journal Materialia has recently published the outcome of a piece of research conducted by a group of researchers comprising several from the Department of Physical Chemistry at the UPV-EHU's Faculty of Science and Technology and BCMaterials, and others from centres at the University of Minho (Portugal).

5 Aug 2020

A SARS-CoV-2 assay using plant proteins

Researchers in South Africa have developed a serological assay that readily detects antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using recombinant viral proteins produced in plants.

5 Aug 2020

Researchers discover how to activate brown fat in humans

The receptor responsible for activating the energy-burning property of brown fat in humans has been identified.

5 Aug 2020

Computational modeling enables accurate visualizations of heart valve behavior

Computational modeling has provided new insights into the heart's vascular system, a complex and mechanically demanding system that remains poorly understood.

5 Aug 2020

NIH-Moderna investigational vaccine protects mice from infection with SARS-CoV-2

The investigational vaccine known as mRNA-1273 protected mice from infection with SARS-CoV-2, the virus that causes COVID-19, according to research published today in Nature.

5 Aug 2020

Evidence for antibody longevity in COVID-19 patients

A study led by researchers at the University of Toronto, Canada, has found evidence that immunoglobulin G (IgG) antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are sustained for at least three months.

5 Aug 2020

Beneficial microbes reprogram the B cell repertoire that produce antibodies

The mammalian gut is home to trillions of microbes which are essential for a healthy immune system and good nutrition.

5 Aug 2020

European Commission approves first drug for hepatitis D

What started off as basic research 25 years ago has now lead to a successfully approved drug: The entry blocker bulevirtide (brand name Hepcludex, formerly known as Myrcludex B), jointly developed by researchers from Heidelberg University Hospital (UKHD) and the Medical Faculty of Heidelberg, the DZIF and other partners, has now been approved by the European Commission.

5 Aug 2020

Discovery of enzyme could provide new route for treating Huntington's disease

Scientists at EPFL's Brain Mind Institute have identified an enzyme that can play a central role in developing a new route of treatment for Huntington's Disease.

5 Aug 2020

Study provides new insights into how ovarian cancer grows and evolves

In a paper published in the journal Cancer Research, professor Levi Waldron, post-doctoral fellow Ludwig Geistlinger, and colleagues at the Institute for Implementation Science in Population Health at the CUNY Graduate School of Public Health and Health Policy) provide new insights into how ovarian cancer grows and evolves within a person.

5 Aug 2020

New research project receives federal funding to expand treatment options for sickle cell patients

A new research project that could impact and expand the discovery of new treatment options for sickle cell patients has received significant federal funding.

5 Aug 2020

Study provides comprehensive update on ACE2 enzyme with key role in SARS-CoV-2 infection

Researchers at Uppsala University have described the presence, throughout the human body, of the enzyme ACE2.

5 Aug 2020

Study shows the strategies tumor cells use to evade immune defense

Scientists are increasingly trying to use the body's own immune system to fight cancer. A new study by the University of Bonn and research institutions in Australia and Switzerland now shows the strategies tumor cells use to evade this attack.

5 Aug 2020

Study demonstrates the dual effect of acetate in immune response

The concentration of acetate increases particularly sharply at the site of an infection in the body. As reported in the journal Cell Metabolism by a team of researchers from the University of Basel and colleagues, acetate supports the function of certain immune cells and thus helps to eliminate pathogens safely and efficiently.

5 Aug 2020

T Cell News and Research

Latest T Cell News and Research

Eosinophils contribute to antiviral host defense mechanisms during influenza

A combination of silk scaffolds and magnetism for regenerating bone tissue

A SARS-CoV-2 assay using plant proteins

Researchers discover how to activate brown fat in humans

Computational modeling enables accurate visualizations of heart valve behavior

NIH-Moderna investigational vaccine protects mice from infection with SARS-CoV-2

Evidence for antibody longevity in COVID-19 patients

Beneficial microbes reprogram the B cell repertoire that produce antibodies

European Commission approves first drug for hepatitis D

Discovery of enzyme could provide new route for treating Huntington's disease

Study provides new insights into how ovarian cancer grows and evolves

New research project receives federal funding to expand treatment options for sickle cell patients

Study provides comprehensive update on ACE2 enzyme with key role in SARS-CoV-2 infection

Study shows the strategies tumor cells use to evade immune defense

Study demonstrates the dual effect of acetate in immune response

Horizon Discovery introduces single cell RNAseq-linked CRISPR screening service

Study: Inhibition of TLK protein stimulates the innate immune system

Researchers develop a novel strategy to fight osteoporosis

Avidity of binding responsible for cross-neutralization of SARS-CoV-1 and SARS-CoV-2

Enzyme could play key role in treating cancer, autoimmune diseases in the airway

Immunology eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in